← Back to Clinical Trials
Recruiting NCT07574398

NCT07574398 A Survey on Growth Development in Children After Liver Transplantation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07574398
Status Recruiting
Phase
Sponsor RenJi Hospital
Condition Growth, Development in Pediatric Liver Transplant Recipients
Study Type OBSERVATIONAL
Enrollment 275 participants
Start Date 2024-11-20
Primary Completion 2029-12-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 1 Year
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 275 participants in total. It began in 2024-11-20 with a primary completion date of 2029-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

A single-center, large-sample, long-term longitudinal study was conducted to explore the trends and characteristics of changes in growth, development in pediatric liver transplant recipients, with the aim of guiding the development of intervention strategies and optimizing follow-up protocols.

Eligibility Criteria

Inclusion Criteria: * Children with end-stage liver disease of various etiologies requiring liver transplantation. * Approved by the ethics committee, and written informed consent has been obtained from the parents/legal guardians. * Age ≤ 1 year (infancy). Exclusion Criteria: * Age older than 1 year old. * Accept liver kidney combined transplantation surgery or second liver transplantation surgery.

Frequently Asked Questions

Who can join the NCT07574398 clinical trial?

This trial is open to participants of all sexes, up to 1 Year, studying Growth, Development in Pediatric Liver Transplant Recipients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07574398 currently recruiting?

Yes, NCT07574398 is actively recruiting participants. Visit ClinicalTrials.gov or contact RenJi Hospital to inquire about joining.

Where is the NCT07574398 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT07574398 clinical trial?

NCT07574398 is sponsored by RenJi Hospital. The trial plans to enroll 275 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology